Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psilocybin”

293 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 293 results

Testing effectiveness (Phase 2)WithdrawnNCT05381974
What this trial is testing

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD

Who this might be right for
Treatment-Resistant Major Depressive Disorder
Massachusetts General Hospital
Early research (Phase 1)Looking for participantsNCT07506395
What this trial is testing

Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder

Who this might be right for
PTSD
University of New Mexico 36
Early research (Phase 1)Looking for participantsNCT05866471
What this trial is testing

The ENHANCE Study: taVNS and Psilocybin

Who this might be right for
HealthyPsychedelic ExperiencesVagus Nerve Stimulation
University of Wisconsin, Madison 108
Very early researchWithdrawnNCT05252598
What this trial is testing

Mood and Cognitive Effects of Psilocybin in Healthy Participants

Who this might be right for
Mood DisturbanceMood ChangeSleep Disturbance+7 more
Optimi Health Corporation
Large-scale testing (Phase 3)Looking for participantsNCT07063862
What this trial is testing

Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)

Who this might be right for
Psychological Distress
Bruyère Health Research Institute. 120
Early research (Phase 1)Study completedNCT05523401
What this trial is testing

Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05421065
What this trial is testing

Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder

Who this might be right for
Alcohol Use Disorder
Peggy C Nopoulos 20
Testing effectiveness (Phase 2)Study completedNCT00302744
What this trial is testing

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Who this might be right for
Anxiety
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT07211438
What this trial is testing

Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression

Who this might be right for
Treatment-Resistant Depression
Centre for Addiction and Mental Health 40
Testing effectiveness (Phase 2)Looking for participantsNCT06001749
What this trial is testing

Psilocybin in Cancer Pain Study

Who this might be right for
Opioid-Related DisordersPain ManagementPain Management and Care+2 more
Yvan Beaussant, MD, MSci 15
Early research (Phase 1)Ended earlyNCT04424225
What this trial is testing

Visual Surround Suppression and Perceptual Expectation Under Psilocybin

Who this might be right for
Perception DisturbanceVisual SuppressionPsychedelic Experiences
University of Minnesota 10
Large-scale testing (Phase 3)Study completedNCT05163496
What this trial is testing

Frontline Clinician Psilocybin Study

Who this might be right for
Burnout, CaregiverBurnout, ProfessionalCOVID-19+3 more
University of Washington 30
Testing effectiveness (Phase 2)Looking for participantsNCT06200155
What this trial is testing

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

Who this might be right for
Depression, AnxietyPsilocybin-Assisted PsychotherapyAdvanced Cancer
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06416085
What this trial is testing

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

Who this might be right for
Advanced CancerStage IV Solid Tumor CancerStage IV Sarcoma of Bone+3 more
University Health Network, Toronto 15
Early research (Phase 1)Not Yet RecruitingNCT07406828
What this trial is testing

Psilocybin After Trauma Surgery for Pain

Who this might be right for
Pain ManagementPostoperative Pain
Trent Emerick 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT07336238
What this trial is testing

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Who this might be right for
AnxietyDepressionHematopoietic and Lymphatic System Neoplasm+1 more
University of Washington 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07373535
What this trial is testing

Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy

Who this might be right for
Treatment-Resistant Major Depressive Disorder
Kyle Greenway 16
Early research (Phase 1)Ended earlyNCT03806985
What this trial is testing

Effects of Psilocybin in Concussion Headache

Who this might be right for
Post-Traumatic Headache
Yale University 12
Early research (Phase 1)Looking for participantsNCT06615908
What this trial is testing

Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted Therapy

Who this might be right for
Persisting Symptoms After Concussion
University of Calgary 40
Not applicableStudy completedNCT05723276
What this trial is testing

Psilocybin in Functional Neurological Disorder

Who this might be right for
Functional Neurological Disorder
King's College London 20
Next Page